Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11279923 Method for purifying RNA

Patent 11279923 was granted and assigned to CureVac on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

March 22, 2022

Patent Application Number

16464152

Date Filed

November 28, 2017

Patent Citations Received

US Patent 11667910 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration

0

US Patent 11760992 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration

US Patent 11786590 Rotavirus vaccines

US Patent 11761009 Artificial nucleic acid molecules for improved protein expression

US Patent 12109275 Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein

0

US Patent 12083190 Rabies vaccine

0

US Patent 11965000 Respiratory syncytial virus (RSV) vaccine

0

US Patent 11834651 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration

0

...

Patent Primary Examiner

Yih-Horng Shiao

CPC Code

The present invention relates to methods for purifying RNA by chromatography under high salt conditions, e.g. by hydrophobic interaction chromatography.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11279923 Method for purifying RNA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool